Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Arpida logo — company profile

Arpida

Founded 1997 31 employees Private Equity Total: $55.00M Biopharma, Biotechnology +2

General Information

Company Name Arpida
Founded Year 1997
Employees 31
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Private Equity
Social

Get notified when Arpida moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Arpida

Arpida is a biopharmaceutical company (SIX: ARPN) headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. Established in 1997, the company focuses on novel drugs that address the growing issue of microbial resistance. Arpida’s primary product candidate is intravenous iclaprim, an antibiotic tailored for severe infections necessitating hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). The company operates within the Biopharma, Biotechnology, Health Care, and Pharmaceutical sectors. Its most recent investment was a Private Equity Round secured on 01 December 2004, with Cita Investissement participating as the investor.

Taxonomy: biopharmaceutical, antibiotic, MRSA, drug development, microbial resistance, infections, IV iclaprim, medical research, pharmaceutical industry, clinical trials, Switzerland, USA, innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1
Investor
01 Dec 2004
Series B •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		23 Oct 2000
Series A •••••• 3
Investor Investor
•••• •••• 		01 Jul 1998
Seed Round •••••• - 01 Dec 1997

Arpida Alternatives & Competitors

Arpida vs
Switzerland Tourism
Switzerland Tourism Switzerland

Marketing organization promoting Switzerland worldwide as an attractive and diverse travel destinati...

378 employees
Entertainment, Travel and Tourism
Arpida vs
Caritas Schweiz
Caritas Schweiz Switzerland

Doing the right thing – for social justice and against poverty – in Switzerland and in around 20 cou...

743 employees
Arpida vs
Swiss Federal Administration
Swiss Federal Administration Switzerland

A premier provider of computer and network security, headquartered in the heart of Bern, Switzerland...

21683 employees
Government and Military

FAQ About Arpida

Arpida (SIX: ARPN) is a biopharmaceutical company headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. It focuses on novel drugs that seek to overcome the growing problem of microbial resistance. Arpida’s leading product candidate is intravenous iclaprim, an...
Arpida was founded in 1997.
Arpida operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
Arpida has approximately 31 employees.
Arpida has completed 4 funding rounds, raising a total of $55.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Arpida include Switzerland Tourism, Caritas Schweiz, Swiss Federal Administration, GPB (Switzerland) Ltd, Switzerland Travel Centre. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arpida and Switzerland Tourism are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Arpida and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy